Application of Multi-Omics Techniques to Androgenetic Alopecia: Current Status and Perspectives

The review discusses the application of multi-omics techniques—genomics, transcriptomics, proteomics, and metabolomics—to understand androgenetic alopecia (AGA), a common hair loss disorder. It highlights how these technologies have identified abnormal changes in mRNA, proteins, and metabolites in AGA patients, offering insights into the disease's pathogenesis and potential therapeutic targets. The integration of multi-omics data can provide a comprehensive understanding of AGA's molecular mechanisms, potentially leading to personalized treatment strategies. The review also notes the challenges of integrative omics analyses and suggests that collaborative studies could enhance the understanding of AGA by focusing on interaction networks involving DNA, RNA, proteins, and metabolites. Key insights include the association of AGA with chemokines, IL-17 pathways, and the Notch signaling pathway. The study identifies several differentially expressed genes (DEGs) and proteins involved in hair follicle miniaturization and hair cycle regulation, such as WNT signaling and oxidative stress pathways. The research also explores the role of specific genes like JAG1 and WNT10A in AGA pathogenesis. Additionally, the document notes the potential of using GGC sequences as predictors for AGA and the impact of AR gene polymorphisms on finasteride treatment efficacy. Overall, the findings suggest that a combination of genetic, molecular, and environmental factors contribute to AGA, offering potential targets for future therapeutic interventions. The document also explores the potential of low-level laser therapy (LLLT) and its effects on hair growth through the Wnt signaling pathway. Additionally, single-cell sequencing has provided insights into the cellular heterogeneity and gene expression profiles during hair follicle development. The research underscores the complexity of AGA and suggests potential therapeutic targets and interventions. It highlights the abnormal expression of specific miRNAs, such as miR-133b and miR-324–3p, which affect hair growth pathways. Studies have identified differentially expressed genes and noncoding RNAs in AGA, suggesting potential targets for treatment. Proteomic analyses have revealed proteins and pathways involved in hair follicle regulation, with potential biomarkers identified for hair growth. Metabolomic studies link AGA to dyslipidemia and stress-related metabolic changes, emphasizing the importance of lipid metabolism in hair growth. Overall, the document underscores the need for further research to elucidate the molecular mechanisms of AGA and develop targeted therapies. Blood metabolomics studies show higher levels of certain fatty acids in AGA patients, suggesting a link with insulin resistance. Animal models and metabolomics research have identified potential treatment pathways, such as the use of tempeh. Urine metabolomics studies reveal changes in amino acid pathways and hormone levels after finasteride treatment, indicating its effectiveness. The integration of multi-omics data can enhance understanding of AGA's molecular mechanisms and lead to personalized treatment strategies. However, challenges include data processing, sample collection, and standardization of methods. The document emphasizes the need for combining clinical data with bioinformatics to improve diagnostic and therapeutic approaches for AGA. The study emphasizes the importance of combining different omics approaches to gain a comprehensive understanding of the disease, as single omics perspectives are insufficient. The document also explores advanced imaging techniques like MRI and infrared spectral imaging for diagnosing and monitoring AGA. These methods, combined with omics data, can enhance diagnosis, treatment, and monitoring, leading to personalized treatment strategies. Despite advancements, challenges remain in data integration, necessitating robust bioinformatic tools. Multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics, provide comprehensive insights into the molecular mechanisms underlying AGA. These techniques have identified key signaling pathways, such as Wnt/β-catenin and hypoxia-inducible factor-1, that are involved in hair follicle regulation and AGA progression. The review emphasizes the potential of these advanced methodologies to uncover novel therapeutic targets and improve the understanding of AGA's etiology, ultimately contributing to the development of more effective treatments.